Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

Treatment Patterns, Outcomes, and Patient-Reported Health-RelatedQuality of Life: A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents (D8220R00004)

  • Details

ClinicalTrials.gov ID: NCT03816683
Diagnosis Type: Lymphomas
USOR Number: 18127

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Myelomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A phase 1 study of SEA-BCMA in patients with relapsed or refractory multiple myeloma (SGNBCMA-001)

  • Details

ClinicalTrials.gov ID: NCT03582033
Diagnosis Type: Myelomas
USOR Number: 18126

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer(64091742PCR3001)

  • Details

ClinicalTrials.gov ID: NCT03748641
Diagnosis Type: Prostate Cancer
USOR Number: 18103

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer(64091742PCR3001)

  • Details

ClinicalTrials.gov ID: NCT03748641
Diagnosis Type: Prostate Cancer
USOR Number: 18103

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 683-5001

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

SGN35-027: Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

  • Details

ClinicalTrials.gov ID: NCT03646123
Diagnosis Type: Lymphomas
USOR Number: 18013

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lymphomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

SGN35-027: Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

  • Details

ClinicalTrials.gov ID: NCT03646123
Diagnosis Type: Lymphomas
USOR Number: 18013

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: Peritoneal Cancer
USOR Number: 17218

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1b/2 Randomized, Controlled Study of AVB-S6-500 in Combination with Pegylated Liposomal Doxorubicin or Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer (AVB500-OC-002)

  • Details

ClinicalTrials.gov ID: NCT03639246
Diagnosis Type: Ovarian Cancer
USOR Number: 17206

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Waldenstr�m macroglobulinemia

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study of the Noncovalent, Reversible Bruton�s Tyrosine Kinase Inhibitor, SNS-062, in Patients With B-Lymphoid Malignancies (062-HEM-102)

  • Details

ClinicalTrials.gov ID: NCT03037645
Diagnosis Type: Waldenstr�m macroglobulinemia
USOR Number: 17195

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: Peritoneal Cancer
USOR Number: 17182

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page
1 2 3 4 5

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.